What is the appropriate acute management of an adult patient with a hemorrhagic stroke?

Management of Hemorrhagic Stroke

For acute hemorrhagic stroke (intracerebral hemorrhage), immediately lower systolic blood pressure to <140 mm Hg within one hour if presenting with SBP 150-220 mm Hg and within 6 hours of symptom onset, using continuous IV antihypertensive infusion with close monitoring. 1, 2

Immediate Assessment and Stabilization

Upon presentation, perform:

• Neuroimaging: CT or MRI to confirm hemorrhagic stroke and exclude ischemic stroke 2, 3
• Focused neurological examination: Use structured assessment (NIHSS or GCS) to quantify severity 2
• Laboratory workup: Complete blood count, PT/INR/PTT, creatinine/eGFR, glucose, cardiac troponin, ECG, toxicology screen, inflammatory markers 2
• Coagulation assessment: Specific tests for DOACs (dilute thrombin time, anti-Xa activity) when applicable 2

Blood Pressure Management

For SBP 150-220 mm Hg (presenting within 6 hours):

• Target: Lower SBP to <140 mm Hg within 1 hour 1
• Method: Continuous IV infusion with close monitoring 1
• Agents:
  • Nicardipine infusion: 5 mg/h, titrate up by 2.5 mg/h every 5-15 minutes, maximum 15 mg/h 4, 5
  • Labetalol: 10-20 mg IV over 1-2 minutes, may repeat 4, 5

For SBP >220 mm Hg:

• Use continuous IV drug infusion with close BP monitoring 1
• Consider sodium nitroprusside if BP not controlled with first-line agents 4, 5

Critical caveat: The 2018 ACC/AHA guideline 1 notes that immediate lowering of SBP to <140 mm Hg is "not of benefit to reduce death or severe disability and can be potentially harmful" (Class III: Harm, Level A), creating some controversy. However, this represents the most recent high-quality evidence and should guide practice, suggesting a more cautious approach than earlier recommendations.

Reversal of Anticoagulation

Immediate reversal is critical for anticoagulant-associated ICH, as these hemorrhages have increased hematoma volume, greater expansion, and increased mortality 2:

• Warfarin: Reverse with prothrombin complex concentrate and vitamin K
• DOACs: Use specific reversal agents when available (idarucizumab for dabigatran, andexanetab alfa for factor Xa inhibitors)
• Heparin: Protamine sulfate

Avoid platelet transfusions for antiplatelet-associated ICH - weak evidence suggests no benefit 6

Airway and Oxygenation

• Oxygen supplementation: Only if saturation <92% 7
• Airway management: Secure airway if GCS declining or unable to protect airway 8

Glucose Management

• Target: Treat if glucose >10 mmol/L (180 mg/dL) with insulin 7
• Avoid both hyperglycemia and hypoglycemia, as both worsen neurological outcomes 5, 7

Temperature Management

• Treat fever: Body temperature >37.5°C is associated with poorer outcomes 7
• Avoid prophylactic temperature-lowering measures outside care bundles 6

Intracranial Pressure Management

For patients with significant mass effect or cerebellar hemorrhage:

• Elevate head of bed: 20-30 degrees to improve venous drainage 5
• Restrict free water: Avoid hypo-osmolar fluids that worsen edema 5
• Correct exacerbating factors: Hypoxemia, hypercarbia, hyperthermia 5
• Osmotic therapy: Mannitol 0.25-0.5 g/kg IV over 20 minutes every 6 hours (maximum 2 g/kg) as temporizing measure 5

Surgical Interventions

• Cerebellar ICH >15 mL: Consider decompressive suboccipital craniectomy - potentially life-saving 5, 6
• Acute hydrocephalus: Ventricular drain placement 5
• Supratentorial ICH: Weak evidence for minimally invasive surgery or open craniotomy; consider on case-by-case basis 6

Seizure Management

• No prophylactic anticonvulsants: Insufficient evidence for routine use 5, 6
• Treat active seizures: Use standard anticonvulsants when seizures occur 5

Venous Thromboembolism Prophylaxis

• Intermittent pneumatic compression: Start early 6
• Low-dose heparin: Decreases DVT/PE risk without increasing cerebral bleeding once hemorrhage stabilized 7, 6

Location of Care

Admit to stroke unit or neuroscience ICU - organized stroke unit care improves outcomes even for hemorrhagic stroke 9, 8, 6, 10

Critical Pitfalls to Avoid

1. Avoid aggressive BP lowering in ischemic stroke mistaken for hemorrhagic - always confirm with imaging first
2. Avoid sublingual nifedipine - causes precipitous BP drops 5
3. Avoid cerebral vasodilators for BP control - may worsen edema 5
4. Do not delay anticoagulation reversal - associated with hematoma expansion and mortality 2
5. Avoid routine platelet transfusions for antiplatelet-associated ICH 6